{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:06:22Z","timestamp":1791187582035,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.meegid.2013.06.025","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T02:16:24Z","timestamp":1372990584000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance"],"prefix":"10.1016","volume":"19","author":[{"given":"Hanadi","family":"Qashqari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Al-Mars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Abuzenadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi","family":"Damanhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaa","family":"El Sayed Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneez","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishtiaq","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.meegid.2013.06.025_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1743-422X-8-71","article-title":"Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: a sequence alignment approach","volume":"15","author":"Afzal","year":"2011","journal-title":"Virol J."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000328327","article-title":"Amino acid substitution in HCV core\/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapy","volume":"55","author":"Akuta","year":"2012","journal-title":"Intervirology"},{"issue":"9","key":"10.1016\/j.meegid.2013.06.025_b0015","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2010.02283.x","article-title":"Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin","volume":"30","author":"Asselah","year":"2010","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2011.09.008","article-title":"IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C","volume":"56","author":"Asselah","year":"2012","journal-title":"J. Hepatol."},{"issue":"Pt 7","key":"10.1016\/j.meegid.2013.06.025_b0025","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1099\/0022-1317-81-7-1631","article-title":"Replication of hepatitis C virus","volume":"81","author":"Bartenschlager","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.06.025_b0030","first-page":"9","article-title":"The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C","volume":"849373","author":"Bellanti","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"4","key":"10.1016\/j.meegid.2013.06.025_b0035","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.23426","article-title":"Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system","volume":"51","author":"Bellecave","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.06.025_b0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1096\/fj.02-0664fje","article-title":"IFN-\u03b1 antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3","volume":"17","author":"Bode","year":"2003","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.meegid.2013.06.025_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/17460913.1.1.103","article-title":"Chronic hepatitis C virus infection: genotyping and its clinical role","volume":"1","author":"Bowden","year":"2006","journal-title":"Future Microbiol."},{"issue":"5","key":"10.1016\/j.meegid.2013.06.025_b0050","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1053\/jhep.2000.19364","article-title":"Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy","volume":"32","author":"Chayama","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.06.025_b0055","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.06.025_b0060","article-title":"HCV genome and life cycle","author":"Chevaliez","year":"2006"},{"issue":"6","key":"10.1016\/j.meegid.2013.06.025_b0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/bi101923r","article-title":"Molecular mechanism by which palmitate inhibits PKR autophosphorylation","volume":"50","author":"Cho","year":"2011","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.meegid.2013.06.025_b0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/liv.12061","article-title":"New therapeutic strategies in HCV: second-generation protease inhibitors","volume":"33","author":"Clark","year":"2013","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.meegid.2013.06.025_b0075","first-page":"16","article-title":"The role of interferon therapy in hepatitis B","volume":"6","author":"Cooksley","year":"2004","journal-title":"MedGenMed: Medscape General Medicine"},{"issue":"13","key":"10.1016\/j.meegid.2013.06.025_b0250","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.02231-07","article-title":"Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses","volume":"82","author":"De Rueda","year":"2008","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.meegid.2013.06.025_b0080","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","article-title":"Functional classification of interferon-stimulated genes identified using microarrays","volume":"69","author":"De Veer","year":"2001","journal-title":"J. Leukocyte Biol."},{"issue":"28","key":"10.1016\/j.meegid.2013.06.025_b0085","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1074\/jbc.R700006200","article-title":"Type I interferon receptors: biochemistry and biological functions","volume":"282","author":"De Weerd","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.meegid.2013.06.025_b0090","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2011.03.010","article-title":"Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis","volume":"55","author":"Deltenre","year":"2011","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.meegid.2013.06.025_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.meegid.2013.06.025_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874279301004010001","article-title":"TLR3 Sensing of viral infection","volume":"4","author":"Dunlevy","year":"2010","journal-title":"Open Infect. Dis. J."},{"key":"10.1016\/j.meegid.2013.06.025_b0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region","volume":"96","author":"Enomoto","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2013.06.025_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5a gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.meegid.2013.06.025_b0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.6","article-title":"Interferons and viral infections","volume":"35","author":"Fensterl","year":"2009","journal-title":"BioFactors"},{"issue":"5","key":"10.1016\/j.meegid.2013.06.025_b0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jhep.2009.10.034","article-title":"Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation","volume":"52","author":"Fukuhara","year":"2009","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.meegid.2013.06.025_b0125","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/JVI.02583-10","article-title":"Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91","volume":"85","author":"Funaoka","year":"2011","journal-title":"J. Virol."},{"issue":"7053","key":"10.1016\/j.meegid.2013.06.025_b0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nature04078","article-title":"Evasion of intracellular host defence by hepatitis C virus","volume":"436","author":"Gale","year":"2005","journal-title":"Nature"},{"issue":"5\u20136","key":"10.1016\/j.meegid.2013.06.025_b0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cytogfr.2007.06.001","article-title":"Interferon, Mx, and viral countermeasures","volume":"18","author":"Haller","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000327783","article-title":"Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response","volume":"55","author":"Hamdi","year":"2012","journal-title":"Intervirology"},{"key":"10.1016\/j.meegid.2013.06.025_b0150","first-page":"w13586","article-title":"Interferons and hepatitis C virus","volume":"142","author":"Heim","year":"2012","journal-title":"Swiss Med. Wkly."},{"issue":"9","key":"10.1016\/j.meegid.2013.06.025_b0160","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/gut.2006.108647","article-title":"The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model","volume":"56","author":"Hourioux","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.meegid.2013.06.025_b0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2006.11.045","article-title":"Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C","volume":"132","author":"Huang","year":"2007","journal-title":"Gastroenterology"},{"issue":"43","key":"10.1016\/j.meegid.2013.06.025_b0170","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.3748\/wjg.14.6627","article-title":"Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2\/3?","volume":"14","author":"Jamal","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/omi.1.2000.5.129","article-title":"Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation","volume":"5","author":"Kato","year":"2000","journal-title":"Microb. Comp. Genomics"},{"key":"10.1016\/j.meegid.2013.06.025_b0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1572-0241.2002.05619.x","article-title":"Amino acid substitutions in the nonstructural region 5A of hepatitis C virus geno- types 2a and 2b and its relation to viral load and response to interferon","volume":"97","author":"Kobayashi","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.meegid.2013.06.025_b0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1872-034X.2012.01046.x","article-title":"Changes in sequences of core region, interferon sensitivity-determining region and interferon and ribavirin resistance-determining region of hepatitis C virus genotype 1 during interferon-alpha and ribavirin therapy, and efficacy of retreatment","volume":"42","author":"Kozuka","year":"2012","journal-title":"Hepatol Res."},{"issue":"5","key":"10.1016\/j.meegid.2013.06.025_b0190","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/jhep.2002.36370","article-title":"Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response","volume":"36","author":"Kumar","year":"2002","journal-title":"Epatology"},{"issue":"16","key":"10.1016\/j.meegid.2013.06.025_b0195","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/JVI.00533-12","article-title":"Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling","volume":"86","author":"Kumthip","year":"2012","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.meegid.2013.06.025_b0200","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3748\/wjg.v13.i17.2416","article-title":"Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy","volume":"13","author":"Le Guillou-Guillemette","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.meegid.2013.06.025_b0205","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.meegid.2013.06.025_b0210","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1128\/JVI.78.17.9285-9294.2004","article-title":"Blocking of the alpha interferon-induced Jak-stat signaling pathway by Japanese encephalitis virus infection","volume":"78","author":"Lin","year":"2004","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.meegid.2013.06.025_b0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2893.2010.01425.x","article-title":"IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon\/ribavirin for chronic hepatitis C genotype 1","volume":"18","author":"Lindh","year":"2011","journal-title":"J Viral Hepat."},{"key":"10.1016\/j.meegid.2013.06.025_b0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.meegid.2013.06.025_b0225","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrd2411","article-title":"The way forward in HCV treatment: finding the right path","volume":"6","author":"Manns","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/eri.09.12","article-title":"Hepatitis C virus virology and new treatment targets","volume":"7","author":"Meier","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"6","key":"10.1016\/j.meegid.2013.06.025_b0240","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0245","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.06.025_b0255","unstructured":"NIH Consensus Statement on Management of hepatitis C, 2002. NIH Consens State Sci Statements. 19 (3), pp. 1\u201346."},{"key":"10.1016\/j.meegid.2013.06.025_b0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1089-3261(02)00065-X","article-title":"Hepatitis C virus genetic variability: pathogenic and clinical implications","volume":"7","author":"Pawlotsky","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.meegid.2013.06.025_b0265","first-page":"5","article-title":"New antiviral agents for hepatitis C. F1000","volume":"4","author":"Pawlotsky","year":"2012"},{"issue":"4","key":"10.1016\/j.meegid.2013.06.025_b0270","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1096-9071(199804)54:4<256::AID-JMV4>3.0.CO;2-3","article-title":"Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C","volume":"54","author":"Pawlotsky","year":"1998","journal-title":"J. Med. Virol."},{"issue":"Pt 7","key":"10.1016\/j.meegid.2013.06.025_b0275","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1099\/vir.0.020644-0","article-title":"Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells","volume":"91","author":"Pazienza","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.06.025_b0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20032","article-title":"Structural biology of hepatitis C virus","volume":"39","author":"Penin","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.06.025_b0285","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.meegid.2013.06.025_b0290","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signaling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2013.06.025_b7240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0167-4889(02)00315-4","article-title":"Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3","volume":"1592","author":"Qadri","year":"2002","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.meegid.2013.06.025_b0295","first-page":"416","article-title":"Induced oxidative stress and activated expression of manganese superoxide dismutase (MnSOD) in HCV-replicating cells: role of JNK, p38MAPK & AP-1","volume":"10","author":"Qadri","year":"2004","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.meegid.2013.06.025_b0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.taap.2008.10.005","article-title":"Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance associated protein-2 (ABCC2)","volume":"234","author":"Qadri","year":"2009","journal-title":"Pharmacol. Toxicol."},{"issue":"44","key":"10.1016\/j.meegid.2013.06.025_b0305","doi-asserted-by":"crossref","first-page":"37340","DOI":"10.1074\/jbc.M112.384743","article-title":"Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT\/enhancer-binding protein \u03b2","volume":"287","author":"Qadri","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.meegid.2013.06.025_b0310","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.3748\/wjg.v12.i44.7075","article-title":"Insulin resistance and hepatitis C","volume":"12","author":"Romero-G\u00f3mez","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.meegid.2013.06.025_b0315","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","article-title":"Hepatitis C virus infection is associated with the development of hepatocellular carcinoma","volume":"87","author":"Saito","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.meegid.2013.06.025_b0320","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl","key":"10.1016\/j.meegid.2013.06.025_b0325","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","article-title":"Antiviral strategies in hepatitis C virus infection","volume":"56","author":"Sarrazin","year":"2012","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.meegid.2013.06.025_b0330","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/JVI.02484-09","article-title":"Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner","volume":"84","author":"Shao","year":"2010","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.meegid.2013.06.025_b0335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3949\/ccjm.69.2.155","article-title":"Advances in treatment of chronic hepatitis C: \u2018pegylated\u2019 interferons","volume":"69","author":"Sharieff","year":"2002","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.meegid.2013.06.025_b0340","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"issue":"Pt 11","key":"10.1016\/j.meegid.2013.06.025_b0345","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","article-title":"Genetic diversity and evolution of hepatitis C virus \u2013 15 years on","volume":"85","author":"Simmonds","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.meegid.2013.06.025_b0350","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.meegid.2013.06.025_b0355","first-page":"363","article-title":"Host genomics and HCV personalized medicine","volume":"42","author":"Slev","year":"2012","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.meegid.2013.06.025_b0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"issue":"5424","key":"10.1016\/j.meegid.2013.06.025_b0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.285.5424.107","article-title":"Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein","volume":"285","author":"Taylor","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.meegid.2013.06.025_b0375","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/2047-783X-16-7-303","article-title":"New hepatitis C therapies in clinical development","volume":"16","author":"Vermehren","year":"2011","journal-title":"Eur. J. Med. Res."},{"issue":"4","key":"10.1016\/j.meegid.2013.06.025_b0380","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bpg.2012.09.011","article-title":"The role of resistance in HCV treatment","volume":"26","author":"Vermehren","year":"2012","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.meegid.2013.06.025_b0385","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.2005.069674","article-title":"Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1","volume":"55","author":"Walsh","year":"2006","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.meegid.2013.06.025_b0390","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/infdis\/jiq165","article-title":"Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients","volume":"203","author":"Yoneda","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.meegid.2013.06.025_b0395","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jhep.2010.11.019","article-title":"IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway","volume":"55","author":"Zhang","year":"2011","journal-title":"J. Hepatol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134813002505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134813002505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T18:31:20Z","timestamp":1688322680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134813002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":76,"alternative-id":["S1567134813002505"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2013.06.025","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2013.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}